Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Active, not recruiting · NCT03796884 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal adenoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2026-10-08 | NCT03796884 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 12 |
| United States Department of Defense | 319 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Philadelphia | United States | 1 |
| VA Puget Sound Health Care Sysem | Seattle | United States | 1 |